Pharma's Almanac: Nice Insight's Content Community

Articles
Expert Interviews
Roundtable
Press Releases
Videos
Thought Leaders

Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing

Recursion Pharmaceuticals

Sort By

Nice Insight is the market research division of That’s Nice LLC, the leading marketing agency serving life sciences.

Explore

About Us
Nice Insight
That's Nice

Reach Out Team

Contact Us
Advertise

My Account

Login/Sign up

Site

Privacy Policy
Terms And Conditions

© 2024 PHARMA’S ALMANAC. All rights reserved.

1 / 1

1 / 1

What key indicators do you look at to predict the future of this industry?

Future of the Industry

What key indicators do you look at to predict the future of this industry?

Pharma's Almanac

PAO-10-022--RT-02October 11, 2022

What is your plan to build a more sustainable business practice in the coming years?

Sustainability

What is your plan to build a more sustainable business practice in the coming years?

Pharma's Almanac

PAO-10-022--RT-01October 11, 2022

In which orphan spaces or unmet medical needs do you think we will see the next treatment innovations?

Unmet Needs

In which orphan spaces or unmet medical needs do you think we will see the next treatment innovations?

Pharma's Almanac

PAO-06-022--RT-01June 24, 2022

What do you consider the biggest challenge that the pharma/biopharma industry currently faces?

Industry Challenges

What do you consider the biggest challenge that the pharma/biopharma industry currently faces?

Pharma's Almanac

O-06-022--RT-01June 24, 2022

2021 Was a Great Year for Biotech IPOs, Depending on When You Got Out

Column: Investment

2021 Was a Great Year for Biotech IPOs, Depending on When You Got Out

Danielle Alvarez

Pharma's Almanac

PAO-03-022-NI-07March 23, 2022